[Professor Buytendijk's miracle drug. The vitamin preparation Eviunis and the risks of scientists doing publicity work].

Studium (Rotterdam, Netherlands) Pub Date : 2010-01-01
Pim Huijnen
{"title":"[Professor Buytendijk's miracle drug. The vitamin preparation Eviunis and the risks of scientists doing publicity work].","authors":"Pim Huijnen","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The discovery of vitamins at the start of the 20th century not only stimulated new areas of scientific research in the field of nutrition and pharmacy; vitamins also turned out to be profitable products for new or existing industries. Consequently, vitamins drove scientists and commercial vitamin producers into each others' arms during the first decades of the century. Several publications--by Harmke Kamminga and Sally Horrocks for instance--deal with the causes and effects of forms of co-operation between science and industry in the nutritional and pharmaceutical sector. They mostly stress--using examples from Great-Britain--the interconnected interests from which both profited: industry-sponsored vitamin research made vitamins available to a larger public of consumers, with scientists authorizing the health claims of the products these companies tried to sell. This article shows how Dutch scientists and vitamin producers were concerned with the same issue in the inter-war period. Not only does it focus on the interconnected interests, but particularly on the conflicts of interests scientists were experiencing whilst performing advisory or research work for the industry. The article singles out E.J.J. Buytendijk, nowadays remembered for his pioneering research in the field of phenomenological psychology after the Second World War, and his involvement with the Swiss vitamin preparation Eviunis at the end of the nineteen-twenties. Buytendijk actively promoted the introduction of this particular preparation on the Dutch market. He was confronted with a growing number of critics, however, after tests demonstrated how the preparation could hardly sustain any of the claims that had been made with regard to its vitamin-like performance. Buytendijk's strongest critics accused him of misusing his scientific authority to sell a fraudulent product--after all, he that maintained his own tests had confirmed Eviunis' claims. A final, state-ordered counter test of Eviunis resulted in the ban of the preparation from the Dutch market. However, it did not condemn Buytendijks commitment to the product. It only concluded that the physiologist had been mistaken in his interpretation of the working of Eviunis. Buytendijk's reputation as a vitamin researcher compromised nonetheless, because of his spirited commitment to a product that turned out to sell an illusion.</p>","PeriodicalId":89624,"journal":{"name":"Studium (Rotterdam, Netherlands)","volume":"3 4","pages":"155-69"},"PeriodicalIF":0.0000,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Studium (Rotterdam, Netherlands)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The discovery of vitamins at the start of the 20th century not only stimulated new areas of scientific research in the field of nutrition and pharmacy; vitamins also turned out to be profitable products for new or existing industries. Consequently, vitamins drove scientists and commercial vitamin producers into each others' arms during the first decades of the century. Several publications--by Harmke Kamminga and Sally Horrocks for instance--deal with the causes and effects of forms of co-operation between science and industry in the nutritional and pharmaceutical sector. They mostly stress--using examples from Great-Britain--the interconnected interests from which both profited: industry-sponsored vitamin research made vitamins available to a larger public of consumers, with scientists authorizing the health claims of the products these companies tried to sell. This article shows how Dutch scientists and vitamin producers were concerned with the same issue in the inter-war period. Not only does it focus on the interconnected interests, but particularly on the conflicts of interests scientists were experiencing whilst performing advisory or research work for the industry. The article singles out E.J.J. Buytendijk, nowadays remembered for his pioneering research in the field of phenomenological psychology after the Second World War, and his involvement with the Swiss vitamin preparation Eviunis at the end of the nineteen-twenties. Buytendijk actively promoted the introduction of this particular preparation on the Dutch market. He was confronted with a growing number of critics, however, after tests demonstrated how the preparation could hardly sustain any of the claims that had been made with regard to its vitamin-like performance. Buytendijk's strongest critics accused him of misusing his scientific authority to sell a fraudulent product--after all, he that maintained his own tests had confirmed Eviunis' claims. A final, state-ordered counter test of Eviunis resulted in the ban of the preparation from the Dutch market. However, it did not condemn Buytendijks commitment to the product. It only concluded that the physiologist had been mistaken in his interpretation of the working of Eviunis. Buytendijk's reputation as a vitamin researcher compromised nonetheless, because of his spirited commitment to a product that turned out to sell an illusion.

布登代克教授的灵丹妙药。维生素制剂evunis和科学家做宣传工作的风险。
20世纪初维生素的发现不仅刺激了营养学和药学领域的科学研究的新领域;维生素也被证明是新兴或现有行业的有利可图的产品。因此,在本世纪头几十年里,维生素促使科学家和商业维生素生产商相互拥抱。一些出版物——例如哈姆克·卡明加和莎莉·霍罗克斯的——讨论了营养和制药领域科学与工业之间各种合作形式的原因和影响。他们大多以英国为例,强调两者都从中获利的相互关联的利益:行业赞助的维生素研究使更多的公众消费者可以获得维生素,科学家授权这些公司试图销售的产品的健康声明。这篇文章展示了荷兰科学家和维生素生产商在两次世界大战期间是如何关注同样的问题的。它不仅关注相互关联的利益,而且特别关注科学家在为该行业提供咨询或研究工作时所经历的利益冲突。这篇文章特别提到了E.J.J.拜登代克,他在二战后在现象学心理学领域的开创性研究,以及他在20世纪20年代末参与瑞士维生素制剂Eviunis,如今人们都记得他。柏登代克积极推动这种特殊制剂在荷兰市场的引入。然而,他面临着越来越多的批评,因为测试表明,这种制剂几乎不能支持任何关于其类似维生素性能的说法。拜登代克最强烈的批评者指责他滥用自己的科学权威来销售欺诈性产品——毕竟,他坚持自己的测试已经证实了埃维乌尼斯的说法。最后,国家下令对Eviunis进行反检测,导致该制剂被禁止进入荷兰市场。然而,它并没有谴责Buytendijks对该产品的承诺。它只是得出结论,这位生理学家在解释埃维尼斯的工作时犯了错误。尽管如此,布登代克作为维生素研究人员的声誉还是受到了损害,因为他对一种产品的热情投入最终被证明是一种错觉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信